Patients with cancer are at increased risk for both suicidal ideation and completed suicide due to a combination of biological and psychological factors that must be addressed to increase quality of life.,Unique to cancer is that the risk of suicide persists more than 15 years past diagnosis.4

In addition to increased suicide risk, patients with head and neck cancers have higher depression scores than the general population even before a cancer diagnosis, leading to the question whether this subset of patients are struggling with a biological cause in addition to diagnosis-related symptoms.5 Complicating these cases is the well-known association of many head and neck cancers with tobacco, alcohol, and other substance use, leading to the question of whether the pre-existing mood disorders lead to substance use that increases the risk of cancer.,Depression is a major risk factor, as it is in the general population, but the cancer population is at higher baseline risk for depression, which has been linked to immunological changes.12 Identification and treatment of depression in cancer patients has been shown to decrease morbidity and mortality.13 read more

Download Exclusive Sample Report (350 Pages PDF with All Related Graphs & Charts) @ major players covered in the pernicious anemia testing market report are AMAG Pharmaceuticals, Siemens Healthcare Private Limited , Pfizer, Inc., Thermo Fisher Scientific Inc., BBI Group, Monobind, Inc., Bio-Rad Laboratories, Inc., GlaxoSmithKline plc, Medline Industries, Inc., Cleveland HeartLab, Inc., Trinity Biotech PLC, Mayo Foundation for Medical Education and Research (MFMER), Laboratory Corporation of America, Takeda Pharmaceutical Company Limited, Emisphere Technologies, DAIICHI SANKYO COMPANY, LIMITED, Sanofi, The Synergy Company, Endo International plc, Merck KGaA and PHARMACOSMOS A/S among other domestic and global players.,This pernicious anemia testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market.,To gain more info on pernicious anemia testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.,For More Insights Get FREE Detailed TOC @ Anemia Testing Market Country Level Analysis

Pernicious anemia testing market is analyzed and market size insights and trends are provided by country, diagnosis test, route of administration, test type and end user as referenced above.,Healthcare Infrastructure growth Installed base and New Technology Penetration read more